| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/18/2006 | CN1237055C 三唑衍生物 Triazole derivatives |
| 01/18/2006 | CN1237052C Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors |
| 01/18/2006 | CN1236816C Tissue volume reduction |
| 01/18/2006 | CN1236814C Faluopeinan medicine composition containing glutathione |
| 01/18/2006 | CN1236813C Self-emulsifying compositions for drugs poorly soluble in water |
| 01/18/2006 | CN1236805C Wanpi ointment for treating skin disease |
| 01/18/2006 | CN1236799C Stomach disease treating medicine and its preparation method |
| 01/18/2006 | CN1236798C External medicine for treating bone tuberculosis |
| 01/18/2006 | CN1236794C Burn treating medicine |
| 01/18/2006 | CN1236792C Brain active effect matter for prevention and treating encephalopathy and developing intelligence and its preparation method |
| 01/18/2006 | CN1236778C New ass hide gelatin preparation and its preparation process |
| 01/18/2006 | CN1236777C Stabilized brivudine topical formulations containing metal oxide pigments |
| 01/18/2006 | CN1236776C Parabuxinidine pills and preparation thereof |
| 01/18/2006 | CN1236775C Compositions and methods for reducing ocular hypertension |
| 01/18/2006 | CN1236774C Highly concentrated stable meloxicam solutions |
| 01/18/2006 | CN1236773C Preparation for analgesia and anesthesia or treating drug dependence |
| 01/18/2006 | CN1236772C Specific medicinal composition for treating hepatitis B |
| 01/18/2006 | CN1236771C Liposome of 10-hydroxycamptothecine, and its prepn. method |
| 01/18/2006 | CN1236770C Gastric acid secretion inhibiting composition |
| 01/18/2006 | CN1236769C Inhibitor for inhibiting cell adhesion |
| 01/18/2006 | CN1236768C Compound blood-pressure reducing medicine |
| 01/18/2006 | CN1236767C Vitronectin receptor antagonists |
| 01/18/2006 | CN1236766C Natural composite preparation for protecting and improving cerebral and heart function and its preparation method |
| 01/18/2006 | CN1236765C Levoimidazole for treating nasal polyp and nasal polyposis |
| 01/18/2006 | CN1236764C Method for preparing a composition |
| 01/18/2006 | CN1236763C Use of an epoxy-sterodal aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects |
| 01/18/2006 | CN1236761C Method to preparing microparticles metoprolol that contain |
| 01/18/2006 | CN1236759C New pharmaceutical preparation for pain management |
| 01/18/2006 | CN1236754C Systems for delivering a cosmetic and/or therapeutic active to oral surfaces using an integral carrier |
| 01/18/2006 | CN1236699C Healthy food |
| 01/17/2006 | US6987194 Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives |
| 01/17/2006 | US6987193 Illudin analogs useful as antitumor agents |
| 01/17/2006 | US6987184 Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof as JNK inhibitors and compositions and methods related |
| 01/17/2006 | US6987175 Slurrying in aqueous solution; antibiotics |
| 01/17/2006 | US6987133 Topical spray for burn treatment and anti-infection |
| 01/17/2006 | US6987132 Enediyne compounds and methods related thereto |
| 01/17/2006 | US6987131 Phenylacetic acid compositions for treating or preventing hypercholesterolemia |
| 01/17/2006 | US6987130 Plant potentiators |
| 01/17/2006 | US6987129 Treating vaginismus, dyspareunia, interstitial cystitis, vulvodynia, vulvar vestibulitis, nonspecific urethritis, female sexual arousal orgasmic disorders or increasing vaginal lubrication, etc. |
| 01/17/2006 | US6987128 Compounds of the N-acylamino amide family, compositions comprising same, and uses |
| 01/17/2006 | US6987127 Regulation of NAD(P)H oxidase growth and transcription in melanoma cells |
| 01/17/2006 | US6987126 Neutralizing agent for clostridium bacterial neurotoxins and preparation method thereof |
| 01/17/2006 | US6987125 Compositions and methods of treating, reducing and preventing cardiovascular diseases and disorders with polymethoxyflavones |
| 01/17/2006 | US6987124 Use of serotonergic compound for a method of treatment of hot flushes in post-menopausal women |
| 01/17/2006 | US6987123 A substituted pyrrole-1-yl-alkyloxy-aryl-2-alkyloxypropanoate derivatives, antilipiemic agents, anticholesterol agents |
| 01/17/2006 | US6987122 Antitumor agents; solid tumors of rectum, lungs |
| 01/17/2006 | US6987121 Compositions and methods for hepatoprotection and treatment of cholestasis |
| 01/17/2006 | US6987120 Pharmaceutical compounds |
| 01/17/2006 | US6987119 Pharmaceutically acceptable salts thereof; their use as inhibitors of Raf kinases and pharmaceutical compositions containing them and anticancer agents |
| 01/17/2006 | US6987118 peroxisome proliferator activator receptor agonists; anticholesterol, antidiabetic agents; 2-Methyl-2-{2-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazole-5-carbonyl]-1,2,3,4-tetrahydro-isoquinolin-7-yloxy}-propionic acid |
| 01/17/2006 | US6987117 Antidepressant azaheterocyclylmethyl derivatives of 1,4-dioxino[2,3-b]pyridine |
| 01/17/2006 | US6987116 Thieno[3,2-b]pyridine-6-carbonitriles and thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors |
| 01/17/2006 | US6987115 Treating bacterial infections with a 1,2,3,4-tetrahydrobeta-carbolin-2-yl-alkyl-1-one; chemical intermediates, amidation |
| 01/17/2006 | US6987114 Antiviral pyrimidinedione derivatives and process for the preparation thereof |
| 01/17/2006 | US6987113 3-hetero-arylideneazaindolin-2-one compounds |
| 01/17/2006 | US6987112 Organic compound having cyano group and insecticides/miticides |
| 01/17/2006 | US6987111 Aripiprazole, olanzapine and haloperidol pamoate salts |
| 01/17/2006 | US6987110 Such as 3-(1-(2-hydroxyethyl)-1H-indol-3-yl)-4-(1-(3-pyridinyl)-1H-indol-3-yl)-1H -pyrrole-2,5-dione |
| 01/17/2006 | US6987109 Solubilized topoisomerase poison agents |
| 01/17/2006 | US6987108 Pharmaceutical formulations of antineoplastic agents and processes of making and using the same |
| 01/17/2006 | US6987107 Method of treating incontinence |
| 01/17/2006 | US6987106 Nootropic agents; Alzheimer's Disease, Schizophrenia; ligands for the a7 subunits of the nicotinic receptor; 4-Bromophenyl-1,4-diazabicyclo[3.2.2]nonane-4-carboxylate |
| 01/17/2006 | US6987105 Prevent apoptosis; vision defects; central nervous system disorders; antiischemic agents; stroke therapy |
| 01/17/2006 | US6987104 Peptidyl deformylase inhibitors used for inhibiting bacteria or preventing bacterial contamination of a cell culture medium |
| 01/17/2006 | US6987103 Treatment of chronic myelogenous leukmia, resistant or intolerant to ST1571, involving homoharringtonine alone or combined with other agents |
| 01/17/2006 | US6987102 Methods to mobilize progenitor/stem cells |
| 01/17/2006 | US6987101 synergistic administration of dospirenone and an estrogen during the luteal phase of female menstrual cycle; side effect reduction |
| 01/17/2006 | US6987100 Pharmaceutical compositions for treating bone lesions in multiple myeloma |
| 01/17/2006 | US6987099 Uncomplexed cyclodextrin compositions for odor control |
| 01/17/2006 | US6987098 Health supplement |
| 01/17/2006 | US6987097 Administering a 6-mercaptopurine drug; determining a level of 6-thioguanine; wherein level of 6-mercaptopurine metabolite greater than predetermined toxic level of 6-mercaptopurine metabolite indicates a need to decrease amount |
| 01/17/2006 | US6987096 genetic engineering of a cyanovirin; gene therapy; exogenous gene expression; use alone or in combination with antiviral agents such as AZT; AIDS therapy |
| 01/17/2006 | US6987095 Fish feed with increased nucleotide content |
| 01/17/2006 | US6987094 Optimized formulation of tobramycin for aerosolization |
| 01/17/2006 | US6987093 Single dose azithromycin |
| 01/17/2006 | US6987092 Indigoid bisindole derivatives |
| 01/17/2006 | US6987005 Where the human SNORF33 receptor has the amino acid sequence SEQ ID NO: 6; encoded by ATCC deposited plasmids; activated by either tyramine, tryptamine, or beta -phenyl-ethylamine; vectors; cells; membranes; nervous system disorders |
| 01/17/2006 | US6987001 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents |
| 01/17/2006 | US6986908 Delta-aminolevulinic acid for prevention and treatment of infection by pathogenic microorganisms and parasite |
| 01/17/2006 | US6986905 Pharmaceutical compositions for treating and saving and the method for the preparation thereof |
| 01/17/2006 | US6986904 Formulation |
| 01/17/2006 | US6986903 Methods for treatment of human skin damaged by laser treatment or chemical peelings and compositions useful in such methods |
| 01/17/2006 | US6986901 Gastrointestinal compositions |
| 01/17/2006 | US6986897 Alcohol-free anti-bacterial wipes |
| 01/17/2006 | US6986896 Administering formulation comprising urea and dermatologically acceptable excipients for therapy of onychomycosis infection of nail area |
| 01/17/2006 | US6986885 Stable and efficacious soft solid product |
| 01/17/2006 | US6986884 Composition and method for treating soft nails |
| 01/17/2006 | US6986740 administering an ultrasound contrast agent such as Rose Bengal; a portion of the contrast agent being retained in tissue of interest; and imaging the tissue with ultrasound to identify the tissue |
| 01/17/2006 | US6986346 Closure-cap and container as a two-chamber cartridge for nebulisers for producing aerosols and active substance formulations, suitable for storage |
| 01/17/2006 | CA2362394C Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 01/17/2006 | CA2351829C Macrolide antibiotics |
| 01/17/2006 | CA2346171C Uses of 1-amino-3-(n,n-dimethylamino)-propylidene-1,1-bisphosphonic acid |
| 01/17/2006 | CA2341865C 6-fluorobicyclo[3.1.0]hexane derivatives |
| 01/17/2006 | CA2338792C Rapidly disintegrable solid preparation |
| 01/17/2006 | CA2334713C Therapeutic biaryl derivatives |
| 01/17/2006 | CA2300069C Naphthalimidobenzamide derivatives |
| 01/17/2006 | CA2286753C Solid pharmaceutical preparation |
| 01/17/2006 | CA2239520C Use of 1-hydroxy-2-pyridones for treating mucosal disorders which are difficult to treat |
| 01/17/2006 | CA2229438C Mercaptoalkylpeptidyl compounds having an imidazole substituent and their use as inhibitors of matrix metalloproteinases (mmp) and/or tumour necrosis factor (tnf) |
| 01/17/2006 | CA2177171C Novel substituted oxazolidines |